UMAMAHESWARA VELLANKI: Open Payments
NPI 1083785158 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 65 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $945 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $368 |
| Otsuka America Pharmaceutical, Inc. | 10 | $172 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Lundbeck LLC | 4 | $61 |
| Almatica Pharma LLC | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Corium, LLC | 2 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: VRAYLAR, REXULTI, Auvelity, LOREEV XR, CAPLYTA, Qelbree, SPRAVATO, Azstarys.
Industry payments across OH — which companies pay providers there.
